Global Intraoperative Radiation Therapy Market Envisioned to Grow by 2031

Global Intraoperative Radiation Therapy Market Size By Technology(Electron IORT & Intraoperative Brachytherapy), By Product and Service(Products, Systems/Accelerators, Applicators & After loaders, Treatment Planning Systems, Accessories, & Services), By Application(Breast Cancer, Brain Tumor, & Lung Cancer), By Geographic Scope And Forecast published by Verified Market Research.

The Global Intraoperative Radiation Therapy Market Demonstrates Consistent Growth Patterns, Estimated to Surge Exponentially from 2024 to 2031.

>>> Download PDF Brochure:

Browse in-depth TOC on “ Global Intraoperative Radiation Therapy Market”

54 – Tables

26 – Figures

85 – Pages

>>> View Detailed Table of Content:

Global Intraoperative Radiation Therapy Market Size and Forecast

Intraoperative radiation therapy (IORT) is a cancer treatment in which ionizing radiation is delivered all at once to a small area of the body during surgery. In comparison to conventional radiation therapy, IORT provides for higher effective doses of radiation to the tumor/tumor bed with less exposure to surrounding healthy tissues. In most solid tumors, surgery is traditionally followed by external beam radiation (EBRT) or chemotherapy to eliminate any microscopic remaining disease and reduce the chance of local recurrence.

The global intraoperative radiation therapy market is expected to be driven by an increase in cancer incidence and prevalence rates throughout the forecast period, since radiation therapy is employed in roughly half of all cancer therapies. According to the American Institute of Cancer Research, around 18 million cancer cases were diagnosed worldwide in 2018, with head and neck cancer accounting for nearly 4% of all cancer cases in the United States in 2017. Furthermore, 65,000 people are expected to get head and neck cancer in the near future.

Moreover, throughout the forecast period, the global intraoperative radiation therapy market is expected to benefit from an increase in demand for highly efficient radiation therapy systems for cancer treatment as well as new product approvals. In recent years, the global market has seen a surge in new product approvals. From 2019 to 2027, this is expected to drive the global market.

Due to the employment of advanced equipment and apparatus, radiation therapy is costly. The overall cost of therapy is determined by the number of sessions, radiation type, and the patient’s health insurance coverage. Radiation therapy for breast cancer is estimated to cost roughly US$ 8,000, while prostate cancer is estimated to cost around US$ 18,000, according to estimates.

Global Intraoperative Radiation Therapy Market Segmentation

The market is divided into Products, Systems/Accelerators, Applicators & After loaders, Treatment Planning Systems, Accessories, and Services based on Product and Service. The goods sector is predicted to have the biggest market share in 2019. The expanding availability of IORT goods, as well as the development of technologically improved mobile systems/accelerators, treatment planning, and growing applications of IORT products in cancer therapy, all, contribute to this segment’s greater share.

Breast Cancer, Brain Tumor, Gastrointestinal Cancer, Head & Neck Cancer, Colorectal Cancer, Endometrial & Cervical Cancer, Lung Cancer, and Other Cancers are the different types of cancers that the market is divided into (penile cancer and prostate cancer). During the projected period, the breast cancer application segment is expected to dominate the intraoperative radiation treatment market. The non-invasive nature of radiation, the rising incidence of breast cancer, and the great success rates attained with IORT are all contributing causes.

The Global Intraoperative Radiation Therapy Market is divided into four regions: North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America, which includes the United States and Canada, accounted for the majority of the intraoperative radiation treatment market. The cheap availability and high adoption of IORT for cancer therapy, the rising prevalence of cancer, and considerable per capita yearly healthcare expenditure in the US and Canada are the primary drivers driving market expansion in this area. Furthermore, organizations like the American Society for Radiation Oncology (ASTRO) have promoted the use of low-energy IORT, which has aided its uptake in North America.

Key Players

iCAD, Inc., Elekta AB, ZEISS Group, GMV Innovating Solutions, IntraOp Medical, Inc., Isoray, Inc., Sensus Healthcare, Inc., Becton, Eckert & Ziegler, Dickinson and Company, Sordina IORT Technologies.

About Verified Market Research

Advanced analytical research solutions within one platform- Verified Market Research. Offering information enriched research studies that include primary and secondary research studies. Verified Market Research assists in understanding holistic industrial factors and trends.

Analysts with high expertise in data gathering and governance utilize industry techniques to collate and examine data at all stages. Our analysts are trained to combine modern data collection techniques, superior research methodology, subject expertise, and years of collective experience to produce informative and accurate research reports.

Verified market research partners with clients to provide insight into strategic and growth analytics; data that help achieve business goals and targets. Our core values include trust, integrity, and authenticity for our clients.

Our research studies help our clients to make superior data-driven decisions, capitalize on future opportunities, optimize efficiency, and keep them competitive by working as their partners to deliver the right information without compromise.

Contact details:

US Toll Free No: +1 (800) 782 1768

Direct US No: +1 (650) 781 4080


Visit Our Website:

Download Sample Report